NEW YORK, Jan. 15, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited ('Hong Kong Pharma' or the 'Company'), a leading provider of OTC pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced the pricing of its initial public offering (the 'Offering') of an aggregate of 1,403,685 ordinary shares of par value $0.001 per share (the 'Ordinary Shares'), at a public offering price of US$4.00 per share, of which 1,000,000 Ordinary Shares are offered by Hong Kong Pharma and 403,685 Ordinary Shares are offered by the selling shareholders of the Company. The Company expects to receive aggregate gross proceeds of US$4 million from the Offering, before deducting underwriting discounts and other related expenses. The Company will not receive any proceeds from any sale of Ordinary Shares by the selling shareholders. In addition, the Company has granted the underwriters a 45-day option (the 'Over-Allotment Option') to purchase up to 150,000 Ordinary Shares to cover over-allotments at the initial public offering price, less underwriting discounts. The Company's Ordinary Shares are expected to begin trading on January 15, 2025, U.S. Eastern time, on the Nasdaq Capital Market under the ticker symbol 'HKPD'. The Offering is expected to close on January 16, 2025, subject to customary closing conditions.